Advancing Cancer Research: Genomic Profiling with QIAseq xHYB Trinity CGP

28 Jan 2026
Cancer Diagnostics Stage
  • Enabling comprehensive cancer biomarker detection using QIAseq xHYB enrichment and Trinity CGP analysis technologies.
  • Identifying novel biomarkers and pathway-level alterations in breast and ovarian cancers.
  • Supporting feasibility studies to integrate comprehensive genomic profiling into translational and precision oncology research

Sponsored by QIAGEN

Speakers
Pinar Uysal-Onganer
Pinar Uysal-Onganer, Reader in Molecular Biology, Cancer Mechanisms and Biomarkers Research Group Leader - University of Westminster